Home › News › Pharma Industry News › Archive

Pharmaceutical Industry News Archive

Get news By email or subscribe to our News feeds.

All News Consumer Pharma New Drugs Pipeline Clinical Trials

July 2007

July 2

Abraxis BioScience Announces Plan to Separate Into Two Independent Public Companies Pro-Pharmaceuticals Terminates Financing Agreement Biogen Idec and Cardiokine Partner to Develop Lixivaptan, a Novel Vasopressin Antagonist Santhera Licenses Omigapil for Treatment of Rare Neuromuscular Diseases Novo Nordisk Increases Transparency on Clinical Trials and Bioethics Novartis Enhances Its Vaccine Pipeline by Gaining Access to Intercell's Key Technologies and Vaccines Programs Luc Missorten Has Decided to Pursue New Opportunities Intercell and Novartis Form World-leading Strategic Partnership to Drive Vaccines Innovation Takeda Wins Patent Infringement Litigation on Appeal Against ANDA Filers for Generic Actos Galapagos Expands Osteoarthritis Alliance with GlaxoSmithKline; GSK Makes €4.4 Million Equity Investment in Galapagos Karo Bio and Wyeth Extend Research Collaboration Thar Instruments Completes the Acquisition of Berger SFC Business from METTLER TOLEDO Genzyme Extends Tender Offer to Acquire Bioenvision, Inc. Dong Wha and Procter & Gamble Pharmaceuticals Form Alliance for Osteoporosis Treatments FDA Finds Consumers Continue to Buy Potentially Risky Drugs Over the Internet FDA Approves First Generic Versions of Lamisil Tablets FDA Issues a Safety Alert for Omalizumab (Marketed as Xolair

July 3

Wyeth Begins Marketing and Distributing BeneFIX in Europe SAVE THE DATE: First International Symposium on Functional and Clinical Aspects of the Tumour Antigen CA-IX to be held on 14 November 2007 in Brussels Tysabri Recommended by NICE for Use in Highly Active Relapsing Remitting Multiple Sclerosis in the Final Appraisal Determination Novartis Plans 30% Increase in US Supplies of Fluvirin Influenza Vaccines and Delivery of 40 Million Doses for 2007/2008 Season Parker Expands Offering for Biotech Market with Acquisition of Mitos Technologies, Inc. Aptilon Announces the Signing of an Important Enterprise Commitment with Merck & Co. One-to-One Marketing Agency Expert Communications Inc. (ECI) Joins Omnicom Group Inc.'s Star Marketing Publicis Groupe to Acquire Muraglia, Calzolari & Associati

July 6

Squeeze Out of Merck Serono Shares Successfully Completed Advanced Medical Optics Confirms $75 Per Share Proposal to Acquire Bausch & Lomb Bausch & Lomb Receives Acquisition Proposal from Advanced Medical Optics for $75.00 Per Share in Cash and AMO Stock Medivir Announces Bristol-Myers Squibb has Terminated Their Agreement for the Development of Medivir's Preclinical Polymerase Inhibitor, MIV-170 FDA - MedWatch - Merck Recalls 3 Lots Of Invanz (ertapenem sodium) Injection Because The Product May Contain Broken Glass Pieces In The Reconstituted Solution For Injection Lorus Therapeutics Announces Revised Closing Date for Proposed Plan of Arrangement FDA-MedWatch- Rocephin (ceftriaxone sodium)- Contraindications, Warnings, Precautions, Adverse Reactions, Dosage And Administration Sections of Labeling Revised Pharma Bloggers Challenge “the Girl from Google”, Critique Relationship Between Pfizer and CROs Leading Academics and Industry Leaders to Keynote at Dedicated Co-Crystals Conference

July 10

Depomed Announces Results of Phase 3 Clinical Trial for Gabapentin GR In Postherpetic Neuralgia High Court in Dublin Rules in Pfizer's Favor in Patent Case, Lipitor Protected from Generic Competition until 2011 Bausch & Lomb Files Preliminary Proxy Statement for Merger Agreement with Warburg Pincus DynoChem Extends Software Agreement with Bristol-Myers Squibb ReGen Biologics To Exhibit at 2007 AOSSM Annual Meeting Epitome Biosystems Initiates Second Partnership with EMD Chemicals for Commercial Products Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline Karo Bio Updates Status in the Merck & Co., Inc. Collaboration Genzyme Completes Tender Offer to Acquire Bioenvision, Inc. Head of Innovative Medicines Initiative at the European Commission to Deliver Keynote Address at ICR European Conference in November IBC Expands Coverage of Case Studies and Projects in Preclinical, Phase 1 and Phase 2 IVT Lab Week Event Combining Method Validation, Laboratory Compliance and Stability Testing

July 13

Valopicitabine Development Program Placed on Clinical Hold in the United States Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program Campbell Alliance to Co-Chair and Speak at ExL Pharma Pricing and Reimbursement Conference Premier Research Group Acquisitions Expand Depth and Breadth of Offerings UCB Announces Registration of Domination and Profit Transfer Agreement Allowing Full Integration of Schwarz Pharma AXIS Healthcare Communications LLC Acquired by Huntsworth PLC Pharmaceutical Companies Enter the Blogging Ring, Industry Bloggers Question FDA’s Revitalization Bill, and Michael Retorts to CNN Jazz Pharmaceuticals Announces Settlement of Government Investigation New DNA Sequencing Technology Enables Insurance Companies and Defense Lawyers to Weed Out Fraud in Class-Action Suits Jazz Pharmaceuticals, Inc. Agrees to Pay $20 Million to Resolve Criminal and Civil Allegations in 'Off-Label' Marketing Investigation

July 16

Schwarz Pharma and UCB, Inc. Announce U.S. Launch of Neupro (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease NicOx Receives Euro 5 Million Milestone From Merck & Co., Inc. as Drug Candidate Enters Clinic Roche and BioCryst Advance BCX-4208/R3421 Into Phase II Psoriasis Trial Affymax Announces Phase 3 Development Plan for Hematide Rotateq and Gardasil Adopted by All Immunization Projects of the Centers for Disease Control and Prevention's Vaccines for Children Program Urigen N.A., Inc. Completes Reverse Merger With Valentis, Inc. King Pharmaceuticals to Sell Rochester, Michigan Manufacturing Facility to JHP Pharmaceuticals Northwest Biotherapeutics, Inc. Responds to Media Reports Boston Scientific Announces Agreement to Settle Product Lawsuits IBM Signs $1.4 Billion Global Strategic Outsourcing Agreement With AstraZeneca Interpublic Launches Mobile Marketing Agency In Joint Venture with Velti, Leading Mobile Technology Company VioQuest Pharmaceuticals Strengthens Balance Sheet Through Sale of Chiral Quest Subsidiary and Completion of Private Placement

July 24

Biogen Idec Reports Second Quarter 2007 Results Panacos to Report Second Quarter Results for 2007 eResearchTechnology, Inc. to Announce 2007 Second Quarter Results on August 2, 2007 Neogen Announces Fourth Quarter 2007 Earnings Webcast Curis to Release Second Quarter 2007 Financial Results and Hold Conference Call on July 31, 2007 Matrixx Initiatives, Inc. Reports 4% Revenue Growth in the First Quarter of Fiscal 2008 and Reduced Seasonal Net Loss Edwards Lifesciences Reports Second Quarter Results Cumberland Pharmaceuticals Inc. Announces Estimated Price Range for Initial Public Offering Amylin Pharmaceuticals Reports Second Quarter Financial Results EXACT Sciences Announces Second Quarter 2007 Results King Pharmaceuticals Announces Date for Release of Second-Quarter 2007 Financial Results and Conference Call Akzo Nobel NV (NL) - Strong operational quarter for the new Akzo Nobel Lilly Reports Strong Second-Quarter Results; Raises Full-Year Sales and EPS Guidance Cipher reports second quarter fiscal 2007 results Hemscott News Alert - Ark Therapeutics Group PLC AVANIR Pharmaceuticals Invites Investors to Third Quarter Conference Call Oriola-KD Corporation's interim report for 1 January - 30 June 2007 Bio-Imaging Technologies to Release Second Quarter 2007 Financial Results and Host Conference Call on August 8, 2007 HAQ Special Meeting of Stockholders to Vote on Proposed Merger of HAQ and PharmAthene Postponed ChemoCentryx Achieves $5 Million Milestone from GlaxoSmithKline for Nomination of CCR1 Small Molecule Development Candidate Former MDS Inc. IT Specialist and Spouse Made More Than $1 Million From Stolen Information About MDS's Impending Merger With Molecular Devices FDA Advisory Committee Recommends Approval of Evista for the Reduction of Risk for Invasive Breast Cancer in Two Populations of Postmenopausal Women

July 25

IMPAX Achieves Milestone in Efforts to File Delinquent Periodic Reports Spanish Court Rules in Pfizer's Favor, Upholds Lipitor Patent Merck & Co., Inc. to Acquire NovaCardia, Inc., to Boost Clinical Pipeline of Cardiovascular Drug Candidates Merck & Co., Inc. to Acquire NovaCardia, Inc., to Boost Clinical Pipeline of Cardiovascular Drug Candidates Genzyme Reports Significant Earnings Growth in Second Quarter Q2/2007: Merck Revenues Soar 67% to EUR 1.8 Billion GSK Reports Second Quarter EPS of 24.0p, Up 11% CER (3% Reported); Share Buy-back Programme Increased to £12 Billion PRA International Enters Into Merger Agreement With Genstar Capital Court Rules In Favor of Sandoz on Toprol Xl Patent Invalidity Cell Therapeutics, Inc. Announces Agreement to Acquire SMi; Gains Global Rights to Brostallicin, in a New Class of Cancer Killing Agents Targeted Genetics' Inflammatory Arthritis Phase I/II Trial Placed on Clinical Hold

July 26

Shire plc: 2007 Guidance Upgraded as Revenue Growth Accelerates Bristol-Myers Squibb Company Reports Financial Results for the Second Quarter and First Half of 2007 AstraZeneca: Second Quarter and Half Year Results 2007 Key Business with Prescription Medicines Continues to Boost Growth at Boehringer Ingelheim Exelixis Retains Right to Develop and Commercialize XL647 Half-year Report 2007: Schwarz Pharma on Track Top Pharmaceutical Websites Visited by Physicians FDA Classifies Baxter's Voluntary Recall Action Regarding Service Documentation as a Class I Recall Further Questions and Answers on the Follow-up to the Viracept Recall Aspreva Announces Restructuring Designed to Drive Long-term Growth UCB: First Half-Year 2007 Financial Results Hydra Biosciences and Pfizer Global Research & Development Sign Collaboration Agreement Cardinal Health Announces Resolution of SEC Investigation; U.S. Attorney's Office Closes Related Inquiry Ranbaxy and GlaxoSmithKline Enter Into an Agreement to Settle Valacyclovir U.S. Patent Litigation

July 27

GlaxoSmithKline and Targacept Form Alliance in Therapeutics for CNS-related Disorders Point Therapeutics Announces Further Management Reductions IMPAX Announces Ruling Related to Generic Rilutek Zelnorm to be Made Available to US Patients Under Restricted Access Program Amgen's Second Quarter 2007 Adjusted Earnings Per Share Increased 7 Percent to $1.12 Kyowa Hakko Three-Month Net Sales up 10.8%; Raises Profit Forecasts Development Discontinued for ANA975, an Early Stage Compound for Treatment of Hepatitis C Virus Infection Ventana Responds to Roche's Unsolicited Tender Offer Extension FDA Permits Restricted Use of Zelnorm for Qualifying Patients FDA Statement on Gene Therapy Clinical Trial Public Statement on Trudexa (adalimumab) - Withdrawal of the Marketing Authorisation in the European Union In Pharma Blogs This Week: A Viagra TV Spot is Critiqued, GlaxoSmithKline is Candid About Alli, and More About the Novartis Whistleblower Diabetes Drugs Increase Risk of Heart Failure, Research Shows

Pharmaceutical Industry News Archive

More News Resources

Printable Version Email Recommend Tweet Save or Share
(web1)